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-Association of lactate level with estimated 30-day mortality and its corresponding adjusted hazard ratio for metformin users and nonusers among patients with a normal renal function or chronic kidney disease one year before ICU admission. ........ 10
Additional Tables  Table S1 - Additional file 1 -Prognostic impact of elevated lactate levels on mortality in critically ill patients with and without preadmission metformin treatment: a Danish registry-based cohort study 3 Figure S2 -Tukey's boxplot of mean lactate levels and mortality rate for patients in the total cohort, among patients with diabetes mellitus, undergoing elective surgery, or with a normal renal function (eGFR ≥60 ml/min/1.72m 2 ) or chronic kidney disease (eGFR <60 ml/min/1.72m 2 ) one year before ICU admission.
Figure S3 -Distribution of metformin users and nonusers based on mean or maximum lactate level
Both for mean lactate level and maximum lactate level around ICU admission, metformin users more often have higher lactate levels than nonusers, illustrated by the rightward shift of the curve. Therefore, more metformin users have a maximum lactate ≥2 mmol/L (dashed line), which is often used to identify severe critical illness, such as septic shock. The x-axis is logarithmically transformed because of the skewed data distribution.
Additional file 1 -Prognostic impact of elevated lactate levels on mortality in critically ill patients with and without preadmission metformin treatment: a Danish registry-based cohort study Figure S4 -Association of lactate level with estimated 30-day mortality for metformin users and nonusers when restricted to complete cases Data were fit by a multivariable-adjusted Cox regression model based on restricted cubic splines constructed with four evenly spaced knots. A dataset restricted to complete cases was used for this analysis. The grey area represents the 95% confidence interval.
Figure S5 -Association of mean lactate level with adjusted odds ratio for 30-day mortality for metformin users and nonusers in the total cohort.
Data were fit by a multivariable-adjusted logistic regression model based on restricted cubic splines constructed with four evenly spaced knots. A multiple imputed dataset was used for this analysis. The grey area represents the 95% confidence interval.
Additional file 1 -Prognostic impact of elevated lactate levels on mortality in critically ill patients with and without preadmission metformin treatment: a Danish registry-based cohort study Figure S6 -Association of first and maximum lactate level, respectively, measured within 12 hours before until 6 hours after ICU admission with estimated 30-day mortality and its corresponding adjusted hazard ratio for metformin users and nonusers in the total cohort. Data were fit by a multivariable-adjusted Cox regression model based on restricted cubic splines constructed with four evenly spaced knots. A multiple imputed dataset was used for this analysis. The grey area represents the 95% confidence interval.
Additional file 1 -Prognostic impact of elevated lactate levels on mortality in critically ill patients with and without preadmission metformin treatment: a Danish registry-based cohort study Figure S7 -Association of lactate level with estimated 30-day mortality and its corresponding adjusted hazard ratio for metformin users and nonusers when including patients with diabetes mellitus. Data were fit by a multivariable-adjusted Cox regression model based on restricted cubic splines constructed with four evenly spaced knots. A multiple imputed dataset was used for this analysis. The grey area represents the 95% confidence interval.
Additional file 1 -Prognostic impact of elevated lactate levels on mortality in critically ill patients with and without preadmission metformin treatment: a Danish registry-based cohort study Figure S8 -Association of lactate level with estimated 30-day mortality and its corresponding adjusted hazard ratio for metformin users and nonusers when only including patients undergoing elective surgery. Data were fit by a multivariable-adjusted Cox regression model based on restricted cubic splines constructed with four evenly spaced knots. A multiple imputed dataset was used for this analysis. The grey area represents the 95% confidence interval.
Additional file 1 -Prognostic impact of elevated lactate levels on mortality in critically ill patients with and without preadmission metformin treatment: a Danish registry-based cohort study Figure S9 -Association of lactate level with estimated 30-day mortality and its corresponding adjusted hazard ratio for metformin users and nonusers among patients with a normal renal function (eGFR ≥60 ml/min/1.72m 2 ) or chronic kidney disease (eGFR <60 ml/min/1.72m 2 ) one year before ICU admission. Data were fit by a multivariable-adjusted Cox regression model based on restricted cubic splines constructed with four evenly spaced knots. A multiple imputed dataset was used for this analysis. The grey area represents the 95% confidence interval.
Additional file 1 -Prognostic impact of elevated lactate levels on mortality in critically ill patients with and without preadmission metformin treatment: a Danish registry-based cohort study (2) 37 (1) 18 (2) Chronic pulmonary disease 6863 (18) 3011 (21) 1563 (18) 1151 (17) 642 (17) 387 (15) 109 (12) Connective tissue disease 1692 (5) 638 (4) 416 (5) 306 (4) 178 (5) 112 (4) 42 (4) Ulcer disease 2165 (6) 883 (6) 447 (5) 390 (6) 221 (6) 158 (6) 66 (7) Mild liver disease 1376 (4) 347 (2) 283 (3) 264 (4) 193 (5) 193 (8) 96 (10) Moderate to severe liver disease 568 (2) 108 (1) 119 (1) 113 (2) 92 (2) 92 (4) 44 (5) Diabetes without endorgan failure 4855 (13) 1802 (12) 1101 (13) 877 (13) 520 (14) 407 (16) 148 (16) Diabetes with endorgan failure 2698 (7) 1025 (7) 603 (7) 472 (7) 279 (8) 235 (9) 84 (9) Moderate to severe renal disease 2464 (7) 1068 (7) 522 (6) 402 (6) 259 (7) 157 (6) (1) AIDS a <50 14 (0) 11 (0) 9 (0) 5 (0) <5 (0) <5 (0) Blood lactate level category based on quintiles and clinically relevant boundaries in mmol/L. Data are expressed as n (%). Data are based on international classification of diseases codes only. a According to Danish regulation, frequencies smaller than five patients not being zero and the corresponding total number of patients are not reported. 
Preadmission disease a
Myocardial infarction 2630 (7) 2334 (7) 296 (9) Congestive heart failure 3520 (9) 3050 (9) 470 (15) Peripheral vascular disease 4104 (11) 3638 (11) 466 (15) Cerebrovascular disease 5065 (14) 4541 (13) 524 (16) Dementia 562 (2) 502 (1) 60 (2) Chronic pulmonary disease 6863 (18) 6215 (18) 648 (20) Connective tissue disease 1692 (5) 1555 (5) 137 (4) Ulcer disease 2165 (6) 1981 (6) 184 (6) Mild liver disease 1376 (4) 1289 (4) 87 (3) Moderate to severe liver disease 568 (2) 529 (2) 39 (1) Diabetes without end-organ failure 4855 (13) 2993 (9) 1862 (58) Diabetes with end-organ failure 2698 (7) 1804 (5) 894 (28) Moderate to severe renal disease 2464 (7) 2298 (7) 166 (5) Hemiplegia 349 (1) 328 (1) 21 (1) Any tumor 5942 (16) Additional file 1 -Prognostic impact of elevated lactate levels on mortality in critically ill patients with and without preadmission metformin treatment: a Danish registry-based cohort study Hazard ratio (HR) with 95% confidence interval (95% CI) was computed using Cox proportional regression analysis based on a dataset restricted to complete cases.
a Adjusted for age, gender, mean of all creatinine measurements 1 year before ICU admission, and previous diagnosis of myocardial infarction, congestive heart failure, peripheral artery disease, cerebrovascular disease, dementia, connective tissue disease, peptic ulcer disease, chronic pulmonary disease, mild to severe liver disease, any tumor, metastatic solid tumor, leukemia, and lymphoma, respectively, 10 years before ICU admission. Codes used for each variable are stated in Appendix 1. Odds ratio (OR) with 95% confidence interval (95% CI) was computed using logistic regression analysis based on a multiple imputed dataset.
a Adjusted for age, gender, last HbA1c measurement within 4 weeks before ICU admission, mean of all creatinine measurements 1 year before ICU admission, and previous diagnosis of myocardial infarction, congestive heart failure, peripheral artery disease, cerebrovascular disease, dementia, connective tissue disease, peptic ulcer disease, chronic pulmonary disease, mild to severe liver disease, any tumor, metastatic solid tumor, leukemia, and lymphoma, respectively, 10 years before ICU admission. Codes used for each variable are stated in Appendix 1.
b Relative excess risk due to interaction (RERI) quantifies interaction on an additive scale, which approaches zero in the absence of interaction.
Additional file 1 -Prognostic impact of elevated lactate levels on mortality in critically ill patients with and without preadmission metformin treatment: a Danish registry-based cohort study (11) 338 (12) 215 (12) 152 (11) 71 (9) 74 (11) 25 (11) Congestive heart failure 1364 (18) 522 (19) 308 (17) 251 (18) 130 (16) 108 (16) 45 (19) Peripheral vascular disease 1309 (17) 490 (18) 300 (17) 241 (17) 136 (17) 100 (15) (14) Connective tissue disease 400 (5) 131 (5) 87 (5) 75 (5) 53 (7) 39 (6) 15 (6) Ulcer disease 553 (7) 197 (7) 123 (7) 111 (8) (2) 60 (2) Chronic pulmonary disease 1728 (22) 1082 (24) 646 (20) Connective tissue disease 400 (5) 263 (6) 137 (4) Ulcer disease 553 (7) 369 (8) 184 (6) Mild liver disease 314 (4) 228 (5) 86 (3) Moderate to severe liver disease 147 (2) 109 (2) 38 (1) Diabetes without end-organ failure 4855 (63) Additional file 1 -Prognostic impact of elevated lactate levels on mortality in critically ill patients with and without preadmission metformin treatment: a Danish registry-based cohort study b Relative excess risk due to interaction (RERI) quantifies interaction on an additive scale, which approaches zero in the absence of interaction.
Additional file 1 -Prognostic impact of elevated lactate levels on mortality in critically ill patients with and without preadmission metformin treatment: a Danish registry-based cohort study Additional file 1 -Prognostic impact of elevated lactate levels on mortality in critically ill patients with and without preadmission metformin treatment: a Danish registry-based cohort study b Relative excess risk due to interaction (RERI) quantifies interaction on an additive scale, which approaches zero in the absence of interaction.
Additional file 1 -Prognostic impact of elevated lactate levels on mortality in critically ill patients with and without preadmission metformin treatment: a Danish registry-based cohort study (7) 360 (7) 208 (5) 137 (6) 87 (6) 26 (5) Congestive heart failure 1574 (7) 611 (7) 399 (7) 258 (6) 155 (7) 111 (7) 40 (7) Peripheral vascular disease 2318 (10) 937 (10) 593 (11) 375 (9) 212 (9) 154 (10) 47 (8) Cerebrovascular disease 3046 (13) 1249 (14) 692 (13) 516 (13) 313 (14) 197 (13) 79 (14) Dementia 312 (1) 106 (1) (23) 192 (25) 104 (20) 23 (14) Connective tissue disease 534 (7) 200 (6) 128 (8) 100 (7) 56 (7) 41 (8) 9 (5) Ulcer disease 689 (9) 
